Compare GIFT & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GIFT | FEMY |
|---|---|---|
| Founded | 1999 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.0M | 22.4M |
| IPO Year | 2019 | 2021 |
| Metric | GIFT | FEMY |
|---|---|---|
| Price | $0.62 | $1.57 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $14.33 |
| AVG Volume (30 Days) | ★ 231.7K | 83.6K |
| Earning Date | 11-09-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 52.05 | 44.71 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $83,181,716.00 | $2,293,313.00 |
| Revenue This Year | $6.02 | N/A |
| Revenue Next Year | $8.42 | $328.45 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 40.77 |
| 52 Week Low | $0.44 | $0.29 |
| 52 Week High | $1.29 | $6.29 |
| Indicator | GIFT | FEMY |
|---|---|---|
| Relative Strength Index (RSI) | 47.77 | 24.20 |
| Support Level | $0.58 | $0.40 |
| Resistance Level | $0.70 | $3.21 |
| Average True Range (ATR) | 0.11 | 0.19 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 65.40 | 10.60 |
Giftify Inc operates in the incentive and rewards industry with a focus on retail, dining, and entertainment experiences, as the owner and operator of digital platforms, CardCash.com, Restaurant.com, and Takeout7.com. CardCash.com is a secondary gift card exchange platform, allowing consumers and retailers to buy and sell gift cards at various scales from several retailers; Restaurant.com is a restaurant-focused digital deals brand, connecting digital consumers and businesses by offering dining, retail, and entertainment deal options at several restaurants and retailers; and Takeout7 is a restaurant technology company offering online ordering solutions and AI-powered digital marketing services. Giftify has one segment, the sale of gift cards and discount certificates to its customers.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.